United Capital Financial Advisers, LLC I Bio, Inc. Transaction History

United Capital Financial Advisers, LLC

  • $11.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.23 - $160.0 $209 - $145,600
-910 Reduced 7.05%
12,000 $2,000
Q1 2022

May 16, 2022
SELL
$0.3 - $0.61 $300 - $610
-1,000 Reduced 7.19%
12,910 $6,000
Q4 2021

Feb 14, 2022
BUY
$0.55 - $1.04 $243 - $459
442 Added 3.28%
13,910 $8,000
Q1 2021

May 14, 2021
BUY
$1.18 - $2.62 $15,892 - $35,286
13,468 New
13,468 $21,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email